Autobio Diagnostics Co Ltd (603658) - Total Liabilities

Latest as of September 2025: CN¥2.88 Billion CNY ≈ $421.64 Million USD

Based on the latest financial reports, Autobio Diagnostics Co Ltd (603658) has total liabilities worth CN¥2.88 Billion CNY (≈ $421.64 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Autobio Diagnostics Co Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Autobio Diagnostics Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Autobio Diagnostics Co Ltd (603658) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Autobio Diagnostics Co Ltd Competitors by Total Liabilities

The table below lists competitors of Autobio Diagnostics Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
China Leadshine Technology Co Ltd SHE:002979	China	CN¥1.27 Billion
Kingclean Electric Co Ltd SHG:603355	China	CN¥12.14 Billion
Tarsus Pharmaceuticals Inc NASDAQ:TARS	USA	$232.18 Million
Kitron ASA OL:KIT	Norway	Nkr525.10 Million
FOCI Fiber Optic Communications TWO:3363	Taiwan	NT$607.99 Million
Vivendi SA PA:VIV	France	€2.51 Billion
Artisan Partners Asset Management Inc NYSE:APAM	USA	$927.61 Million
Customers Bancorp, Inc. NYSE:CUBI	USA	$23.74 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Autobio Diagnostics Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 603658 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.58	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Autobio Diagnostics Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Autobio Diagnostics Co Ltd (2011–2024)

The table below shows the annual total liabilities of Autobio Diagnostics Co Ltd from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.18 Billion ≈ $465.81 Million	+10.23%
2023-12-31	CN¥2.89 Billion ≈ $422.57 Million	+12.80%
2022-12-31	CN¥2.56 Billion ≈ $374.63 Million	+39.94%
2021-12-31	CN¥1.83 Billion ≈ $267.71 Million	+17.89%
2020-12-31	CN¥1.55 Billion ≈ $227.08 Million	-4.34%
2019-12-31	CN¥1.62 Billion ≈ $237.39 Million	+134.88%
2018-12-31	CN¥690.69 Million ≈ $101.07 Million	+38.74%
2017-12-31	CN¥497.85 Million ≈ $72.85 Million	+182.04%
2016-12-31	CN¥176.52 Million ≈ $25.83 Million	-22.24%
2015-12-31	CN¥227.01 Million ≈ $33.22 Million	+50.26%
2014-12-31	CN¥151.08 Million ≈ $22.11 Million	+115.85%
2013-12-31	CN¥70.00 Million ≈ $10.24 Million	+50.82%
2012-12-31	CN¥46.41 Million ≈ $6.79 Million	+17.92%
2011-12-31	CN¥39.36 Million ≈ $5.76 Million	--

About Autobio Diagnostics Co Ltd

SHG:603658 China Medical Devices

Market Cap

$2.55 Billion

CN¥17.42 Billion CNY

Market Cap Rank

#5537 Global

#1095 in China

Share Price

CN¥30.49

Change (1 day)

-1.74%

52-Week Range

CN¥29.71 - CN¥42.46

All Time High

CN¥131.73